Module 11: Regulation on Affordability of Health Goods and Services
Home / My courses / Module 11: Regulation on Affordability of Health Goods and Services / Post-Test / Post-Test
Started on Saturday, 31 August 2024, 4:35 PM
State Finished
Completed on Saturday, 31 August 2024, 4:39 PM
Time taken 4 mins
Grade 30.00 out of 30.00 (100%)
Question 1
Correct
Mark 1.00 out of 1.00
Unit cost reflected in the Purchase Order which is the basis in the computation of price mark-ups:
a. Compounding fee
b. Prevailing price
c. Acquisition cost
d. Overhead cost
Your answer is correct.
The correct answer is:
Acquisition cost
Question 2
Correct
Mark 1.00 out of 1.00
The following strategies are aimed to make price information of all health goods and services available and accessible,
EXCEPT:
a. The Price list must be updated and part of the requirements for licensing and accreditation.
b. The prices and fees must be presented in a fixed amount.
c. The price list must be in a conspicuous area of the health facility.
d. The price list must be posted on the facility’s website.
Your answer is correct.
The correct answer is:
The prices and fees must be presented in a fixed amount.
Question 3
Correct
Mark 1.00 out of 1.00
The following statements are correct regarding price mark-ups of drugs and medicines in DOH-owned health facilities,
EXCEPT:
a. The prevailing mark-up rate of medicines of the same brand should be followed during Emergency Procurement.
b. The level of mark-up should remain the same regardless of the quantity supplied by the hospital pharmacies.
c. The government has the right to issue a price freeze or suggested retail prices during public health emergencies.
d. Random monitoring of medicines prices shall be done regularly at DOH-owned facilities by the FDA.
Your answer is correct.
The correct answer is:
Random monitoring of medicines prices shall be done regularly at DOH-owned facilities by the FDA.
Question 4
Correct
Mark 1.00 out of 1.00
The following is responsible to synthesize the data submitted by the end-user and Health Technology Assessment Council:
a. Price Negotiation Board
b. DOH Pharmaceutical Division
c. Price Negotiation Board Secretariat
d. Price Negotiation Board Technical Working Group
Your answer is correct.
The correct answer is:
Price Negotiation Board Technical Working Group
Question 5
Correct
Mark 1.00 out of 1.00
Consumer’s guide that provides information on where to get the cheapest medicines within their area:
a. Electronic Drug Price Monitoring System
b. Philippine National Formulary
c. Primary Care Formulary
d. Drug Price Watch
Your answer is correct.
The correct answer is:
Drug Price Watch
Question 6
Correct
Mark 1.00 out of 1.00
Drug or medical device that has been granted intellectual property rights, which provides a legal right to exclude others
from making, using, selling, and importing for a limited period of years:
a. Proprietary health commodity
b. Single-sourced health commodity
c. Innovative health commodity
d. Patented health commodity
Your answer is correct.
The correct answer is:
Patented health commodity
Question 7
Correct
Mark 1.00 out of 1.00
The following statements are true regarding the appeal of any health facility whose license or accreditation is revoked or
suspended due to noncompliance to the provisions of Administrative Order 2021-008 on public access to price information
of all health goods and services, EXCEPT:
a. A notice of appeal shall be filed within ten (10) days upon receipt of the notice of the decision.
b. The notice of appeal shall be filed to the Head of the DOH Health Regulation Team (HRT)
c. The decision of the Head of DOH HRT shall be final and executory.
d. All pertinent documents and records of the applicant shall be elevated by the Health Facility and Services Regulatory
Bureau or Center for Health Development to the HRT.
Your answer is correct.
The correct answer is:
The decision of the Head of DOH HRT shall be final and executory.
Question 8
Correct
Mark 1.00 out of 1.00
The prices of the following shall be included in the list of price information in all DOH-owned health facilities:
a. Type of accommodation
b. Medical and Surgical Procedures
c. Professional Fees
d. Drugs, medicines, and medical supplies
e. All of the above are correct.
f. Only A, B, and D are correct.
Your answer is correct.
The correct answer is:
All of the above are correct.
Question 9
Correct
Mark 1.00 out of 1.00
The following statements are correct for successful outcomes of price negotiation, EXCEPT:
a. A Memorandum of Agreement shall be executed for drugs and vaccines listed in the Philippine National Formulary.
b. Negotiated prices are only valid for one (1) year except when there is a Multi-Year Obligational Authority.
c. The final agreed price must be made publicly available.
d. Companies are given fifteen (15) working days upon receipt of the decision of the Board to submit an appeal.
Your answer is correct.
The correct answer is:
Companies are given fifteen (15) working days upon receipt of the decision of the Board to submit an appeal.
Question 10
Correct
Mark 1.00 out of 1.00
The following are true regarding generic alternatives of drugs and medicines:
a. Similar active ingredients as the branded medicines
b. Proven safe, effective, and of the same quality as branded medicines
c. Cheaper than branded medicines
d. All of the above are correct.
e. Only B and C are correct.
Your answer is correct.
The correct answer is:
All of the above are correct.
Question 11
Correct
Mark 1.00 out of 1.00
The following are true in the imposition of maximum retail price (MRP) on drugs and medicines:
a. MRP is applicable to a specific brand and strength and form of drugs and medicines.
b. Special discounts are still honored for drugs and medicines with MRP.
c. MRP is VAT exempted.
d. All of the above are correct.
e. Only B and C are correct.
Your answer is correct.
The correct answer is:
Only B and C are correct.
Question 12
Correct
Mark 1.00 out of 1.00
The following are the objectives of the Administrative Order 2020-0043 (Guidelines on Ensuring the Affordability of Essential
Medicines in DOH Facilities Through the Regulation of Price Mark-ups):
a. Provide mechanisms for setting the allowable mark-ups on essential medicines being dispensed or charged to the
patients and to PhilHealth in all DOH hospitals
b. Provide guidelines for the enforcement, implementation, and monitoring of the mark-up scheme across all DOH
facilities nationwide
c. Alignment of the policy in the implementation of the Universal Health Care which mandates the prescribing of uniform
rules and structures in setting mark-ups for drugs and medical devices and supplies
d. All of the above are correct.
e. Only A and B are correct.
Your answer is correct.
The correct answer is:
All of the above are correct.
Question 13
Correct
Mark 1.00 out of 1.00
In the implementation of Maximum Retail Price (MRP), the Department of Trade and Industry is responsible for:
a. Investigation of alleged violations of MRP
b. Dissemination of Information, Education and Communication materials related to the imposition of MRP
c. Monitoring both suppliers and drug outlets on their compliance to MRP
d. Submission of quarterly price monitoring reports to the Secretary of Health
Your answer is correct.
The correct answer is:
Submission of quarterly price monitoring reports to the Secretary of Health
Question 14
Correct
Mark 1.00 out of 1.00
The following prerequisites and preparation apply for health commodities that are already listed in the Philippine National
Formulary:
a. The Health Technology Assessment Council (HTAC) may nominate these drugs and vaccines.
b. End-users may nominate these drugs and vaccines.
c. The Price Negotiation Board Secretariat must issue a Letter of Intent to the companies to submit a price offer or
proposal.
d. The HTAC Secretariat must submit the list of health commodities recommended for price negotiation.
e. Both A and D are correct.
f. Both B and C are correct.
Your answer is correct.
The correct answer is:
Both B and C are correct.
Question 15
Correct
Mark 1.00 out of 1.00
The following statements are true regarding the composition of the Drug Price Advisory Board, EXCEPT:
a. There shall be a public health and an epidemiology expert as members of the council.
b. The council members shall elect the chairperson.
c. The members of the council are co-terminus with the Secretary of Health.
d. The number of council members shall be odd.
Your answer is correct.
The correct answer is:
The council members shall elect the chairperson.
Question 16
Correct
Mark 1.00 out of 1.00
The following are the benefits of centralized price negotiation thru the Price Negotiation Board:
a. Promote transparency in price setting for health commodities
b. Improve efficiency in government spending on health commodities
c. Guarantee access to affordable and quality health commodities
d. All of the above are correct.
e. Only A and B are correct.
Your answer is correct.
The correct answer is:
All of the above are correct.
Question 17
Correct
Mark 1.00 out of 1.00
Drug or medical device that is used, produced, or marketed under exclusive legal right and protected by patent:
a. Single-sourced health commodity
b. Patented health commodity
c. Proprietary health commodity
d. Innovative health commodity
Your answer is correct.
The correct answer is:
Proprietary health commodity
Question 18
Correct
Mark 1.00 out of 1.00
The countries used as the basis for external reference pricing in determining the maximum retail price of drugs and
medicines:
a. United States of America
b. United Kingdom
c. Canada
d. Australia
e. All of the above are correct.
f. Only B, C, and D are correct.
Your answer is correct.
The correct answer is:
Only B, C, and D are correct.
Question 19
Correct
Mark 1.00 out of 1.00
Drug or medicine with an active pharmaceutical ingredient or molecule that was first originally marketed globally:
a. Generic drug
b. Comparator drug
c. Branded medicine
d. Controlled medicine
Your answer is correct.
The correct answer is:
Comparator drug
Question 20
Correct
Mark 1.00 out of 1.00
The following statements are true regarding the guidelines on public access to price information of all health goods and
services in DOH-owned health facilities:
a. Health facilities must ensure that an updated price list is accessible to the public and patients at all times.
b. The price list must be itemized comprehensively.
c. The Department of Trade and Industry shall monitor the compliance of health facilities to the price list.
d. All of the above are correct.
e. Only A and B are correct.
Your answer is correct.
The correct answer is:
Only A and B are correct.
Question 21
Correct
Mark 1.00 out of 1.00
The following statements are correct regarding the computation of retail prices for highly specialized drugs:
a. Mark-up price is computed similar to the regular essential medicines with an additional compounding fee.
b. A fixed-rate compounding fee is added on top of the mark-up.
c. No compounding fee is added for highly specialized drugs availed by outpatients.
d. All of the above are correct.
e. Only A and C are correct.
Your answer is correct.
The correct answer is:
Only A and C are correct.
Question 22
Correct
Mark 1.00 out of 1.00
The independent technical body duly authorized and delegated by the Secretary of Health to provide technical advice and
guidance to the DOH in implementing appropriate measures that promote and ensure access to affordable quality drugs
and medicines for all consumers in the Philippines:
a. Public Health Ethics Committee
b. Drug Price Advisory Council
c. Price Negotiation Board
d. Health Technology Assessment Council
Your answer is correct.
The correct answer is:
Drug Price Advisory Council
Question 23
Correct
Mark 1.00 out of 1.00
The following are the criteria being used by the Drug Price Advisory Board for selecting drugs and medicines for
consideration under maximum retail pricing, EXCEPT:
a. Highest disease burden
b. Patient groups and medical societies recommendations
c. Limited competition
d. Low price differential from other countries
Your answer is correct.
The correct answer is:
Low price differential from other countries
Question 24
Correct
Mark 1.00 out of 1.00
The agency responsible to investigate alleged violations of Maximum Retail/Wholesale Price of drugs and medicines in
accordance with relevant laws:
a. PhilHealth
b. Department of Health
c. Department of Trade and Industry
d. Food and Drug Administration
Your answer is correct.
The correct answer is:
Food and Drug Administration
Question 25
Correct
Mark 1.00 out of 1.00
The following agencies must have representatives as members of the Price Negotiation Board, EXCEPT:
a. Department of Trade and Industry
b. FDA
c. PhilHealth
d. DOH
Your answer is correct.
The correct answer is:
FDA
Question 26
Correct
Mark 1.00 out of 1.00
In the implementation of price mark-ups in DOH-owned health facilities, the following is responsible to endorse to the
Commission on Audit any report of non-compliance observed by the Internal Audit Service:
a. DOH Pharmaceutical Division
b. DOH Hospitals
c. Drug Price Advisory Committee
d. Regional Drug Price Monitoring Office
e. All of the above are correct.
Your answer is correct.
The correct answer is:
DOH Pharmaceutical Division
Question 27
Correct
Mark 1.00 out of 1.00
The DOH office responsible for the review of the medicines to be included in the Primary Care Formulary:
a. Centers for Health Development
b. Health Facility Development Bureau
c. Health Technology Assessment Unit
d. Pharmaceutical Division
Your answer is correct.
The correct answer is:
Health Technology Assessment Unit
Question 28
Correct
Mark 1.00 out of 1.00
A re-negotiation may be conducted as deemed appropriate by the end-user before the expiration of the Memorandum of
Agreement based on a set of criteria that includes the following:
a. New price has been observed in other countries.
b. New price has been submitted to the end-user by the company.
c. Updated epidemiologic report or relevant real-world evidence data is available.
d. All of the above are correct.
e. Only A and B are correct.
Your answer is correct.
The correct answer is:
All of the above are correct.
Question 29
Correct
Mark 1.00 out of 1.00
As provided in the UHC Act, drugs and medicines listed in the Primary Care Formulary (PCF) shall have fairly priced generic
equivalents. The formulation of the PCF shall be based on:
a. Common morbidities and mortalities in the locality
b. Prevailing disease patterns in the country
c. Local needs
d. All of the above are correct.
e. Only A and C are correct.
Your answer is correct.
The correct answer is:
Only A and C are correct.
Question 30
Correct
Mark 1.00 out of 1.00
Ongoing expense of operating a business that cannot be conveniently traced to any particular cost unit:
a. Compounding fee
b. Overhead cost
c. Prevailing price
d. Acquisition cost
Your answer is correct.
The correct answer is:
Overhead cost
Previous Activity
Jump to...
Next Activity